Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion
Eli Lilly & Co. has signed an AI-powered drug development deal with Insilico Medicine that could be worth up to…
Tag: Insilico
AI Drug Firm Insilico Debuts in Hong Kong After $293 Million IPO
AI-biotechnology firm Insilico Medicine Cayman TopCo is set to debut in Hong Kong on Tuesday after raising $293 million in…
Insilico Medicine CEO on Business Strategy
Alex Zhavoronkov, Founder and CEO at Insilico Medicine, discusses the company’s business strategy and the opportunities with AI drug discovery.…